Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/51007, first published .
Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis

Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis

Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis

Authors of this article:

Yiming Li1 Author Orcid Image ;   Jianfu Li2 Author Orcid Image ;   Yifang Dang1 Author Orcid Image ;   Yong Chen3 Author Orcid Image ;   Cui Tao2 Author Orcid Image

Journals

  1. Li J, Li Y, Pan Y, Guo J, Sun Z, Li F, He Y, Tao C. Mapping vaccine names in clinical trials to vaccine ontology using cascaded fine-tuned domain-specific language models. Journal of Biomedical Semantics 2024;15(1) View
  2. Zhang K, Dang Y, Li Y, Tao C, Hur J, He Y. Impact of climate change on vaccine responses and inequity. Nature Climate Change 2024;14(12):1216 View
  3. Quach T, Miglis M, Tian L, Bonilla H, Yang P, Grossman L, Paleru A, Xin V, Tiwari A, Shafer R, Geng L. Post-COVID-19 Vaccination and Long COVID: Insights from Patient-Reported Data. Vaccines 2024;12(12):1427 View
  4. Li Y, Viswaroopan D, He W, Li J, Zuo X, Xu H, Tao C. Improving entity recognition using ensembles of deep learning and fine-tuned large language models: A case study on adverse event extraction from VAERS and social media. Journal of Biomedical Informatics 2025;163:104789 View
  5. Huffman A, Gautam M, Gandhi A, Du P, Austin L, Roan K, Zheng J, He Y. Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase. Frontiers in Cellular and Infection Microbiology 2025;15 View
  6. Li Y, Li J, Li M, Yu E, Rhee D, Amith M, Tang L, Savas L, Cui L, Tao C. VaxBot-HPV: a GPT-based chatbot for answering HPV vaccine-related questions. JAMIA Open 2024;8(1) View
  7. Miyauchi K, Usui J, Shimizu T, Hattori A, Nomura S, Higashi T, Usui T, Saito C, Kai H, Yamagata K. A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination. CEN Case Reports 2025;14(5):679 View
  8. Zhou Y, Wang Y, Feng Y, Zhang H, Sun T, Xu J. Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system. Frontiers in Cellular and Infection Microbiology 2025;15 View
  9. El Houdi M, Skhoun H, Guennoun A, Dakka N, Ameziane El Hassani R, Ouzzif Z, El Baghdadi J. Deciphering TLR and JAK/STAT pathways: genetic variants and targeted therapies in COVID-19. Molecular Biology Reports 2025;52(1) View
  10. Salako A, Musa A, Ige F, Abdullahi A, James A, Ekama S, Odubela O, Idigbe I, Ajibaye O, Altaf M, Adeneye K, Akinsolu F, Olojo I, Okwuraiwe A, Egharevba H, Ekpenyong M, Elemuwa U, Ezenyi I, Bitrus F, Odubela O, Oba A, Idris G, Yusuf J, Akande I, Nwaiwu S, Omale L, Oyewunmi O, Agbabiaka A, Eyinade O, Ogunwale J, Garba A, Bello Y, Musa B, Ezejiofor O, Ejiro B, Iwalokun B, Rosenzweig L, Adigwe O, Adeyeye C, Shuaib F, Wicek W, Hamada Y, Ezechi O, Gupta R, Salako B. Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial. Scientific Reports 2025;15(1) View
  11. Ilangovan K, Radley D, Patton M, Shittu E, Lino M, Goulas C, Swanson K, Anderson A, Gurtman A, Munjal I. Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine. Vaccines 2025;13(8):827 View
  12. Fu H, Huang Y, Wang X, Zhang Y, Liu Y, Su Y, Pan L. Pharmacovigilance-based 12-year post-marketing safety analysis of quadrivalent influenza vaccines in children: a VAERS surveillance study. Frontiers in Pediatrics 2025;13 View
  13. Jędrzejczyk T, Tyrańska-Fobke A, Konieczna A, Ślęzak D, Waśkow M, Brzychcy K, Robakowski P, Robakowska M. Self-Reporting of Post-Vaccination Symptoms in the COVID-19 Vaccination Process for Teachers in a North Region of Poland. Vaccines 2025;13(10):1054 View